ARTICLE | Clinical News
XR9576: Phase IIa
February 26, 2001 8:00 AM UTC
In an open-label U.S. Phase IIa pharmacokinetic trial of XR9576 in combination with Navelbine vinorelbine, interim data showed that no clinically significant interaction occurred between XR9576 and v...